CE-326597

DB12694InvestigationalSmall molecule

CE-326,597 has been used in trials studying the treatment of Obesity.

Mechanism: Pharmacologically active on Cholecystokinin receptor type A
Curator reviewed
Formula / weight: C₃₇H₃₄N₆O₂ · 594.719 g/mol (avg)
Code names: CE-326,597

Resolves to

Compound

Structure

InChIKeyUBNMGTSDHSQBEL-PMERELPUSA-NSMILESCC(C)N(CC1=CC=CC=C1)C(=O)CN1C2=CC=CC=C2N2C(=NN=C2C2=CC=CC=C2)[C@H](CC2=CNC3=CC=CC=C23)C1=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with CE-326597, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.